bepridil has been researched along with Cardiac Complex, Premature in 2 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coumel, P | 1 |
| Leenhardt, A | 1 |
| Nestico, PF | 1 |
| Morganroth, J | 1 |
| Horowitz, LN | 1 |
| Mulhern, C | 1 |
1 trial available for bepridil and Cardiac Complex, Premature
| Article | Year |
|---|---|
Bepridil hydrochloride for treatment of benign or potentially lethal ventricular arrhythmias.
Topics: Bepridil; Calcium Channel Blockers; Cardiac Complexes, Premature; Clinical Trials as Topic; Electroc | 1986 |
1 other study available for bepridil and Cardiac Complex, Premature
| Article | Year |
|---|---|
Antiarrhythmic drugs: how to evaluate them?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Bepridil; Cardiac Complexes, Premature; Electro | 1994 |